Recent advances in our understanding of the molecular genetics of Wilms and other renal tumors are discussed by Kathy Pritchard-Jones, Programme Director for the Integrated Cancer Programme at UCLPartners and Chief Medical Officer for London Cancer.

Image courtesy of interviewee